Advancing Scientific Discovery in the Agentic AI Era

Short summary

NVIDIA promotes BioNeMo, its generative AI platform for accelerating pharmaceutical drug discovery and protein structure prediction. The platform leverages foundation models and accelerated computing to help researchers and pharmaceutical companies work at unprecedented speed.

• •NVIDIA BioNeMo uses generative AI for drug discovery and protein structure prediction
• •Platform combines accelerated computing with open foundation models
• •Positioned as enabling faster scientific research workflows

Generated with AI, which can make mistakes.